A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Assess the Safety and Efficacy or Pre-Treatment With DF01 During Late Pregnancy in Reducing Prolonged Labor
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Tafoxiparin (Primary)
- Indications Labour disorders; Pregnancy
- Focus Therapeutic Use
- 04 Sep 2009 Primary endpoint has not been met, according to a Karolinska Development media release.
- 20 May 2009 Actual patient number (263) added as reported by ClinicalTrials.gov.
- 20 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.